an internationally leading provider of RNA technology products, including RNA isolation and mRNA amplification kits, synthetic long RNAs and DNAs as well as functional mRNAs.
We are committed to direct and flexible customer interactions with life science industries and academic research institutions around the world, including on-site technical support.
AmpTec CEOs Dr. Peter Scheinert and Dr. Guido Krupp
Our products meet the requirements of the finest international standards:
We have implemented a quality management system, certified by DQS MED.
AmpTec has been acquired by Millipore Sigma, a leading science and technology company, based in Germany.
Last year, AmpTec celebrated its fifteenth anniversary, and this acquisition marks an exciting new chapter for our company. AmpTec’s more than 40 employees are thrilled to join Millipore Sigma and are confident that our PCR-based technology and combined expertise will allow us to offer customers innovative technologies, products and services to help advance life-enhancing therapeutics.